POSTMENOPAUSAL OSTEOPOROTIC WOMEN TREATED WITH PTH 1-84: EVALUATION OF OUTCOMES

被引：0
|
作者：
Pastore, Renato [1 ]
Chioma, Laura [2 ]
Borboni, Patrizia [2 ]
Vancieri, Giuseppe [2 ]
Mentuccia, Daniela [1 ]
Frajese, Giovanni Vanni [3 ]
机构：
[1] Osped Fatebenefratelli S Giovanni Calibita Isola, UOC Endocrinol, Rome, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
[3] Univ Cassino, Fac Sci Motorie & Salute, Frosinone, Italy
来源：
OSTEOPOROSIS INTERNATIONAL | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：395 / 395
页数：1
相关论文
共 50 条
  • [21] Serum calcium values in postmenopausal women with primary osteoporosis after one month of treatment with PTH(1-84)
    Diaz-Curiel, M.
    Hosking, D.
    Rizzoli, R.
    Delmas, P.
    Brandi, M. L.
    Felsenberg, D.
    Hyldstrup, L. H.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S222 - S222
  • [22] Bone turnover markers and BMD remain elevated in postmenopausal osteoporotic women through a full 24 months of treatment with human parathyroid hormone 1-84 (PTH).
    Greenspan, S. L.
    Hanley, D. A.
    Morris, S.
    Marriott, T. B.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S114 - S114
  • [23] Measuring the effect of Cinacalcet on 1-84 PTH and 7-84 PTH
    Cantor, T
    Amerling, R
    Modugno, M
    Goretsky, S
    CLINICAL CHEMISTRY, 2005, 51 : A237 - A237
  • [24] The PTH (1-84)/non-PTH (1-84) ratio is a risk factor for cardiovascular events in hemodialysis patients
    Zitt, E.
    Kirsch, A. H.
    Haueis, M.
    Strasak, A.
    Neyer, U.
    Mayer, G.
    Rosenkranz, A. R.
    CLINICAL NEPHROLOGY, 2011, 75 (04) : 309 - 318
  • [25] Efficacy of PTH (1-84) on vertebral and non-vertebral fractures in postmenopausal women with a high risk of vertebral fractures
    Roux, C.
    Martin, O. Illera
    Clausen, J.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S48 - S48
  • [26] TERIPARATIDE AND PTH 1-84 IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH BISPHOSPHONATE-RESISTANT OSTEOPOROSIS: A CASE-CONTROL STUDY
    Loriggiola, L.
    Camozzi, V. I.
    Schiavon, L.
    Salva, M.
    Basso, S. M. M.
    Lumachi, F.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S193 - S194
  • [27] A comparison of strontium ranelate and PTH(1-84)
    Henriksen, Kim
    Christiansen, Claus
    Karsdal, Morten A.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (02) : 153 - 155
  • [28] CHANGES IN SERUM CALCIUM AND PTH LEVELS DURING THE FIRST 6 MONTHS, IN PATIENTS INCLUDED IN THE STEP STUDY (STUDY OF IMAGING TECHNIQUES IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS TREATED WITH PTH 1-84)
    Martinez, G.
    Palacios, S.
    Martinez, E.
    Perez-Abela, A.
    Diez-Perez, A.
    Perez-Castrillon, J. L.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 329 - 329
  • [29] Bone histology validation of the scantibodies 1-84 PTH (CAP) assay and the 1-84 PTH/Large C terminal PTH fragments ratio.
    Tokumoto, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 688A - 688A
  • [30] PTH Substitution Therapy for Chronic Hypoparathyroidism: PTH 1-84 and Palopegteriparatide
    Palermo, Andrea
    Naciu, Anda Mihaela
    Donovan, Yu Kwang Tay
    Tabacco, Gaia
    Zavatta, Guido
    CURRENT OSTEOPOROSIS REPORTS, 2025, 23 (01)
12345